Elopak ASA NOK (0AB3)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 33.75 |
|---|---|
| 52-week range | 33.45 – 55.50 |
| Return, 1 month / 3 months | −4.9% / −2.8% |
| Return, 1 year / 3 years | −22.1% / +74.9% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 36.7% |
| Worst drawdown (1 year) | -37.2% |
| Average daily value traded | 0.58M NOK |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Elopak is a Norwegian packaging company that makes cartons and filling machines for liquid food and drinks. Its customers are food and beverage producers who use its cartons for products such as milk, juice and plant-based drinks. The company also supplies the equipment and services that go with those cartons. Elopak is based in Norway and serves customers in many countries around the world.
Elopak ASA NOK trades under the code 0AB3 on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Elopak ASA NOK (0AB3) trades on the London Exchange in UK. It last closed at NOK 33.75 on 23 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 2,730 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 22.1% and over the last three months it fell 2.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.6% | ||
| From 52-week high | -38.7% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.8% | ||
| 6-month return | 0.2% | ||
| 12-month return, skipping the last month | -18.0% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.2% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.58M NOK | ||
| Zero-volume days | 3.3% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | −4.9% |
| 3 months | −2.8% |
| 6 months | +0.2% |
| 1 year | −22.1% |
| 3 years | +74.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 34.89 / 39.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | NOK 0.6908 |
| 15 May 2026 | NOK 1.0986 |
| 16 Oct 2025 | NOK 0.5858 |
| 15 May 2025 | NOK 0.9269 |
| 14 May 2024 | NOK 1.4600 |
| 12 May 2023 | NOK 0.8600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.